Inventor
Naoko Yamane
Inventor
Machida, JP
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture20%
C12NMicroorganisms or enzymes11%
C12YEnzymes11%
A61KPreparations for medical, dental or toiletry purposes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
10,233,247Method of modulating the activity of functional immune molecules201910,233,475Antibody composition-producing cell20199,637,545'Method of modulating the activity of functional immune molecules'20179,409,982'Antibody composition-producing cell'20168,895,266'Antibody composition-producing cell'20148,679,491'Method of modulating the activity of functional immune molecules'20148,367,407'Cells with altered fucosylation and producing antibodies therefrom'20138,329,443'Antibody composition-producing cell'20128,158,760'Glycoengineered, recombinant antibody'20128,110,195'Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody'20128,101,185'Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation'20128,067,232'Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase'20118,039,595'Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation'20117,846,725'Antibody composition-producing cell in which enzyme expression is inhibited by RNAi'20107,763,246'Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor'20107,741,442'Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation'20107,737,325'Antibody composition-producing cell'20107,718,175'Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein'20107,708,992'Methods for producing antibody compositions with increased ADCC'20107,708,997'Method of modulating the activity of functional immune molecules'20107,687,061'Method of modulating the activity of functional immune molecules to Her-2'20107,682,611'Method of modulating the activity of functional immune molecules to CXCR4 protein'20107,682,610'Method of modulating the activity of functional immune molecules'20107,655,228'Method of modulating the activity of functional immune molecules to GM2'20107,651,688'Method of modulating the activity of functional immune molecules to CD52'20107,425,446'Antibody composition-producing cell'20087,393,683'Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase'20087,214,775'Method of modulating the activity of functional immune molecules'20076,946,292'Cells producing antibody compositions with increased antibody dependent cytotoxic activity'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2019Based in Machida, JP· patent location history
2010–2019Patents assigned to KYOWA HAKKO KIRIN CO LTD (24)· patent assignee history
2011–2014Patents assigned to HANAI NOBUO (7)· patent assignee history
2011–2014Patents assigned to HOSAKA EMI (7)· patent assignee history
2011–2014Patents assigned to KANDA YUTAKA (7)· patent assignee history
2011–2014Patents assigned to NAKAMURA KAZUYASU (7)· patent assignee history
2012Based in Chiyoda-ku, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KYOWA HAKKO KIRIN CO LTD | 24 | 2010–2019 |
| HANAI NOBUO | 7 | 2011–2014 |
| HOSAKA EMI | 7 | 2011–2014 |
| KANDA YUTAKA | 7 | 2011–2014 |
| NAKAMURA KAZUYASU | 7 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Machida, JP | 27 | 2005–2019 |
| Chiyoda-ku, JP | 2 | 2012 |